RxNorm 100213

Bifidobacterium infantis

RxNorm Semantic Concepts

RxNorm semantic concepts for the RxCUI 100213 unique identifier include: Bifidobacterium infantis (12776525).

RxNorm Atom ID: 12776525 - Ingredient
Bifidobacterium infantis

RXCUI:
100213 - RxNorm Unique Identifier for a concept (Concept ID)
LAT:
ENG - Language of the Term
RXAUI:
12776525 - Unique identifier for the atom (RxNorm Atom ID)
Is Prescribable?
YES - This drug is part of the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States. The Current Prescribable subset also includes over-the-counter drugs.
Concept Description:
Bifidobacterium infantis - Description of concept identifier
Term Type (TTY):
IN - Term type in source with name and description
Term Type Name:
Ingredient - Name of term type in source
Term Type Description:
A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). - Description of term type in source
Code:
100213 - "Most useful" source asserted identifier. If the source vocabulary has more than one identifier, or a RxNorm-generated source entry identifier. (if the source vocabulary has none.)
Suppress Flag:
N
Suppressible flag. Values = N, O, Y, or E. N - not suppressible. O - Specific individual names (atoms) set as Obsolete because the name is no longer provided by the original source. Y - Suppressed by RxNorm editor. E - unquantified, non-prescribable drug with related quantified, prescribable drugs. NLM strongly recommends that users not alter editor-assigned suppressibility.
CVF:
4096 - Content view flag. RxNorm includes one value, '4096', to denote inclusion in the Current Prescribable Content subset. All rows with CVF='4096' can be found in the subset.
RxNorm to UNII Crosswalk:
EF3U3H7I76 - BIFIDOBACTERIUM LONGUM INFANTIS () - RxNorm to UNII (Unique Ingredient Identifier) Crosswalk
Source:
RXNORM - Concept source abbreviation
Source Name:
RxNorm Vocabulary - The official name for a source
Source Version:
20AA_240401F - The source version
Source Date:
March 04, 2024 - RxNorm data last updated
Source License Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source license contact information
Source Content Contact:
RxNorm Customer Service

U.S. National Library of Medicine
8600 Rockville Pike

Bethesda
MD
United States
20894
(888) FIND-NLM

[email protected]
https://www.nlm.nih.gov/research/umls/rxnorm/ - The source content contact information
Source Short Name:
RxNorm work done by the National Library of Medicine - The short name of a source as used by the NLM Knowledge Source Server

* This product uses publicly available data courtesy of the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Patient Education

Bifidobacteria


What is it? Bifidobacteria species are probiotics ("good" bacteria) that live in the intestines. They may help with diarrhea, constipation, and other intestinal disorders.

"Good" bacteria such as bifidobacteria can help break down food, absorb nutrients, and fight off "bad" organisms that might cause diseases.

Bifidobacteria are commonly used for diarrhea, constipation, and irritable bowel syndrome (IBS). They're also used for preventing the common cold or flu, and lots of other conditions, but there is no good scientific evidence to support many of these uses. There is also no good evidence to support using bifidobacteria for COVID-19.
[Learn More]


* Please review the disclaimer below.